Capricor Therapeutics to Host Key Opinion Leader Call on Cardiac Complications of Duchenne Muscular Dystrophy
-To Provide Clinical Development Update on CAP-1002--Final HOPE-2 Data Now Expected by Mid-Q2-LOS ANGELES, April 13, 2020 (GLOBE NEWSWIRE) — […]